Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
33.20
+0.24 (0.73%)
May 6, 2026, 2:08 PM EDT - Market open
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $2.07 billion as of May 6, 2026. Its market cap has increased by 344.02% in one year.
Market Cap
2.07B
Enterprise Value
1.70B
1-Year Change
344.02%
Ranking
Category
Stock Price
$33.20
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $2.07B, an increase of 156.99%. That is a compound annual growth rate of 14.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 2.05B | 13.21% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 2.16B |
| Ascentage Pharma Group International | 2.10B |
| Mesoblast | 2.06B |
| Ocular Therapeutix | 2.05B |
| Tyra Biosciences | 2.02B |
| Aurinia Pharmaceuticals | 1.99B |
| Zymeworks | 1.96B |
| Trevi Therapeutics | 1.94B |